
Mon, 11 Apr 2022 China Legal Trends CJO Staff Contributors Team
In December 2021, in a case concluded by the Intellectual Property Court of China’s Supreme People’s Court, the court made a preliminary review on the “reverse payment agreement for drug patent” for the first time.